About
Metabolic & Age-related treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
495
By Phase
PHASE2: 3PHASE1: 5
By Status
COMPLETED: 6RECRUITING: 3
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06845553Lead Sponsor
A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients
PHASE2Recruiting
60 participants
Started: Aug 19, 2025 · Completed: Dec 31, 2026
NCT06329141Lead Sponsor
A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients
PHASE2Recruiting
90 participants
Started: Aug 1, 2024 · Completed: Jun 30, 2026
NCT07109635Lead Sponsor
Post Market Study of Safety and Performance of RefillHA Volume+ for Facial Soft Tissue Augmentation and Correction of Wrinkles and Folds
N/ACompleted
46 participants
Started: Feb 19, 2024 · Completed: May 18, 2025
NCT05642377Lead Sponsor
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects
PHASE1Recruiting
40 participants
Started: Nov 22, 2022 · Completed: Jan 31, 2025
NCT05310032Lead Sponsor
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses
PHASE1Completed
36 participants
Started: Apr 21, 2022 · Completed: Mar 31, 2023
Locations (1)
Headquarters
Suwon, Korea
Map
Loading map...